National Cancer Institute Notice of Meeting, 29758-29759 [2013-12015]
Download as PDF
<![CDATA[
29758
Federal Register / Vol. 78, No. 98 / Tuesday, May 21, 2013 / Notices
TKELLEY on DSK3SPTVN1PROD with NOTICES
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Program
Project Supplement: Electron Detector.
Date: June 6, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Warwick Seattle Hotel, 401 Lenora
Street, Seattle, WA 98121.
Contact Person: Wallace Ip, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5128,
MSC 7840, Bethesda, MD 20892, 301–435–
1191, ipws@mail.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Bacterial Pathogenesis Study Section.
Date: June 11, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Washington DC/
Bethesda, 7301 Waverly Street, Bethesda, MD
20814.
Contact Person: Richard G. Kostriken,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 301–402–
4454, kostrikr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Bacterial
Pathogens.
Date: June 11, 2013.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Washington DC/
Bethesda, 7301 Waverly Street, Bethesda, MD
20814.
Contact Person: Alexander D. Politis,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3210,
MSC 7808, Bethesda, MD 20892, (301) 435–
1150, politisa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–13–
009: Secondary Dataset Analyses in Heart,
Lung, and Blood Diseasesand Sleep
Disorders.
Date: June 17, 2013
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications
Place: Courtyard by Marriott, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
VerDate Mar<15>2010
17:07 May 20, 2013
Jkt 229001
Contact Person: Julia Krushkal, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, 301–435–
1782, krushkalj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–13–
009: Secondary Dataset Analyses in Heart,
Lung, and Blood Diseases and Sleep
Disorders: Conflicts.
Date: June 17, 2013
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications
Place: Courtyard by Marriott, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: George Vogler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3140,
MSC 7770, Bethesda, MD 20892, (301) 237–
2693, voglergp@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Bioinformatics in Surgical Sciences, Imaging,
and Independent Living.
Date: June 17, 2013.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, 301–237–
9870, xuguofen@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 15, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–12016 Filed 5–20–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meeting of the
National Cancer Advisory Board and
NCI Board of Scientific Advisors.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
A portion of the National Cancer
Advisory Board meeting will be closed
to the public in accordance with the
provisions set forth in sections
552b(c)(4), and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Advisory Board; Ad hoc Subcommittee on
Global Cancer Research.
Open: June 23, 2013, 5:00 p.m. to 6:30 p.m.
Agenda: Discussion on Global Cancer
Research.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Bethesda, Maryland
20814.
Contact Person: Dr. Edward Trimble,
Executive Secretary, NCAB Ad hoc
Subcommittee on Global Cancer Research,
National Cancer Institute, National Institutes
of Health, 9609 Medical Center Drive, Room
3W–562, Bethesda, MD 20892, (240) 276–
5796, trimblet@mail.nih.gov.
Name of Committee: National Cancer
Advisory Board, Ad hoc Subcommittee on
Communications.
Open: June 23, 2013, 6:40 p.m. to 8:10 p.m.
Agenda: Discussion on Communications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Bethesda, Maryland
20814.
Contact Person: Dr. Lenora Johnson,
Executive Secretary, NCAB Ad hoc
Subcommittee on Communications National
Cancer Institute, National Institutes of
Health, 9606 Medical Center Drive, Room
2E–454, Bethesda, MD 20892, (240) 276–
6680, johnslen@mail.nih.gov.
Name of Committee: National Cancer
Advisory Board and NCI Board of Scientific
Advisors.
Open: June 24, 2013, 9:00 a.m. to 3:30 p.m.
Agenda: Joint meeting of the National
Cancer Advisory Board, and NCI Board of
Scientific Advisors; NCI Board of Scientific
Advisors Concepts Review and NCI
Director’s reports and NCAB presentations.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 9606
Medical Center Drive, Room 7W–444,
Bethesda, MD 20892, (240) 276–6340.
Name of Committee: National Cancer
Advisory Board.
Closed: June 24, 2013, 3:30 p.m. to 5:00
p.m.
Agenda: Review of NCAB Grant
Applications.
E:\FR\FM\21MYN1.SGM
21MYN1
Federal Register / Vol. 78, No. 98 / Tuesday, May 21, 2013 / Notices
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 9606
Medical Center Drive, Room
7W–444, Bethesda, MD 20892, (240)
276–6340.
Name of Committee: National Cancer
Advisory Board.
Open: June 25, 2013, 9:00 a.m. to 12:00
p.m.
Agenda: Joint meeting of the National
Cancer Advisory Board and NCI Board of
Scientific Advisors.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 9606
Medical Center Drive, Room
7W–444, Bethesda, MD 20892, (240)
276–6340.
TKELLEY on DSK3SPTVN1PROD with NOTICES
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: NCAB:
deainfo.nci.nih.gov/advisory/ncab.htm,
BSA: deainfo.nci.nih.gov/advisory/bsa/
bsa.htm, where an agenda and any
additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 15, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–12015 Filed 5–20–13; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
17:07 May 20, 2013
Jkt 229001
DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2012–0061]
Chemical Facility Anti-Terrorism
Standards Personnel Surety Program
National Protection and
Programs Directorate, DHS.
ACTION: Information collection request;
extension of comment period.
AGENCY:
SUMMARY: The Department of Homeland
Security (DHS), National Protection and
Programs Directorate (NPPD), Office of
Infrastructure Protection (IP),
Infrastructure Security Compliance
Division (ISCD) is extending the
comment period for the CFATS
Personnel Surety Program Notice and
Request for Comments published on
March 22, 2013, at 78 FR 17680, entitled
‘‘Information Collection Request;
Chemical Facility Anti-Terrorism
Standards Personnel Surety Program’’
for 14 days.1 This extension of the
comment period is designed to
accommodate requests from the public
for more time to review the Notice and
Request for Comments.
DATES: The comment period for the
CFATS Personnel Surety Program
Notice and Request for Comments
published on March 22, 2013, at 78 FR
17680, is extended. Comments and
related material must be submitted to
the docket by June 4, 2013.
ADDRESSES: Interested persons are
invited to submit comments on the
proposed information collection
through the Federal eRulemaking Portal
at https://www.regulations.gov. All
submissions received must include the
words ‘‘Department of Homeland
Security’’ and the docket number DHS–
2012–0061. Except as provided below,
comments received will be posted
without alteration at https://
www.regulations.gov, including any
personal information provided.
Comments that include trade secrets,
confidential commercial or financial
information, Chemical-terrorism
Vulnerability Information (CVI),2
Sensitive Security Information (SSI),3 or
Protected Critical Infrastructure
Information (PCII) 4 should not be
1 The 60-day CFATS Personnel Surety Program
Notice and Request for Comments may be viewed
at https://federalregister.gov/a/2013-06184.
2 For more information about CVI see 6 CFR
27.400 and the CVI Procedural Manual at https://
www.dhs.gov/xlibrary/assets/
chemsec_cvi_proceduresmanual.pdf.
3 For more information about SSI see 49 CFR Part
1520 and the SSI Program Web page at https://
www.tsa.gov/ssi.
4 For more information about PCII see 6 CFR Part
29 and the PCII Program Web page at https://
PO 00000
Frm 00063
Fmt 4703
Sfmt 9990
29759
submitted to the public regulatory
docket. Please submit such comments
separately from other comments in
response to this notice. Comments
containing trade secrets, confidential
commercial or financial information,
CVI, SSI, or PCII should be
appropriately marked and packaged in
accordance with applicable
requirements and submitted by mail to
the DHS/NPPD/IP/ISCD CFATS
Program Manager at the Department of
Homeland Security, 245 Murray Lane
SW., Mail Stop 0610, Arlington, VA
20528–0610. Comments must be
identified by docket number DHS–
2012–0061.
On March
22, 2013, the Department published a
notice entitled ‘‘Information Collection
Request; Chemical Facility AntiTerrorism Standards Personnel Surety
Program’’ at 78 FR 17680. In the March
22, 2013 notice, the Department stated
that it will submit a new Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act
(PRA) of 1995 (Pub. L. 104–13, 44 U.S.C.
Chapter 35). The purpose of the March
22, 2013 notice was to solicit comments
prior to the submission of the ICR to
OMB. The March 22, 2013 notice
described the nature of the information
collection, the categories of
respondents, the estimated burden (in
hours), and the estimated burden cost
necessary to implement the Chemical
Facility Anti-Terrorism Standards
(CFATS) Personnel Surety Program
pursuant to 6 CFR 27.230(a)(12)(iv).
The Department believes that the
public would benefit from additional
time to provide comments on the March
22, 2013 CFATS Personnel Surety
Program Notice and Request for
Comments. For that reason, the
Department is extending the comment
period for a period of 14 days.
Comments will now be accepted until
June 4, 2013.
SUPPLEMENTARY INFORMATION:
Dated: May 15, 2013.
Scott Libby,
Deputy Chief Information Officer, National
Protection and Programs Directorate,
Department of Homeland Security.
[FR Doc. 2013–12059 Filed 5–20–13; 8:45 am]
BILLING CODE 9110–09–P
www.dhs.gov/protected-critical-infrastructureinformation-pcii-program.
E:\FR\FM\21MYN1.SGM
21MYN1
]]>Agencies
[Federal Register Volume 78, Number 98 (Tuesday, May 21, 2013)]
[Notices]
[Pages 29758-29759]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12015]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of meeting of the
National Cancer Advisory Board and NCI Board of Scientific Advisors.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
A portion of the National Cancer Advisory Board meeting will be
closed to the public in accordance with the provisions set forth in
sections 552b(c)(4), and 552b(c)(6), Title 5 U.S.C., as amended. The
grant applications and the discussions could disclose confidential
trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board; Ad hoc
Subcommittee on Global Cancer Research.
Open: June 23, 2013, 5:00 p.m. to 6:30 p.m.
Agenda: Discussion on Global Cancer Research.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center,
Bethesda, Maryland 20814.
Contact Person: Dr. Edward Trimble, Executive Secretary, NCAB Ad
hoc Subcommittee on Global Cancer Research, National Cancer
Institute, National Institutes of Health, 9609 Medical Center Drive,
Room 3W-562, Bethesda, MD 20892, (240) 276-5796,
trimblet@mail.nih.gov.
Name of Committee: National Cancer Advisory Board, Ad hoc
Subcommittee on Communications.
Open: June 23, 2013, 6:40 p.m. to 8:10 p.m.
Agenda: Discussion on Communications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center,
Bethesda, Maryland 20814.
Contact Person: Dr. Lenora Johnson, Executive Secretary, NCAB Ad
hoc Subcommittee on Communications National Cancer Institute,
National Institutes of Health, 9606 Medical Center Drive, Room 2E-
454, Bethesda, MD 20892, (240) 276-6680, johnslen@mail.nih.gov.
Name of Committee: National Cancer Advisory Board and NCI Board
of Scientific Advisors.
Open: June 24, 2013, 9:00 a.m. to 3:30 p.m.
Agenda: Joint meeting of the National Cancer Advisory Board, and
NCI Board of Scientific Advisors; NCI Board of Scientific Advisors
Concepts Review and NCI Director's reports and NCAB presentations.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray, Executive Secretary,
National Cancer Institute, National Institutes of Health, 9606
Medical Center Drive, Room 7W-444, Bethesda, MD 20892, (240) 276-
6340.
Name of Committee: National Cancer Advisory Board.
Closed: June 24, 2013, 3:30 p.m. to 5:00 p.m.
Agenda: Review of NCAB Grant Applications.
[[Page 29759]]
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray, Executive Secretary,
National Cancer Institute, National Institutes of Health, 9606
Medical Center Drive, Room 7W-444, Bethesda, MD 20892, (240) 276-
6340.
Name of Committee: National Cancer Advisory Board.
Open: June 25, 2013, 9:00 a.m. to 12:00 p.m.
Agenda: Joint meeting of the National Cancer Advisory Board and
NCI Board of Scientific Advisors.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray, Executive Secretary,
National Cancer Institute, National Institutes of Health, 9606
Medical Center Drive, Room 7W-444, Bethesda, MD 20892, (240) 276-
6340.>
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one form
of identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home
page: NCAB: deainfo.nci.nih.gov/advisory/ncab.htm, BSA:
deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an agenda and any
additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: May 15, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-12015 Filed 5-20-13; 8:45 am]
BILLING CODE 4140-01-P
